Condition: Aortic Aneurysm and Dissection · Cardiac Valve Disease · Thoracic Aortic Aneurysm · Sponsor: Petrovsky National Research Centre of Surgery
According to the literature, presepsin was recommended not only as an effective indicator in the diagnosis of sepsis in intensive care units, but also as a reliable prognostic marker of postoperative inflammatory processes in cardiac surgery. Previous study carried out in Petrovsky NRCS related to biomarkers in cardiac surgery and presepsin in particular showed good sensitivity in infection complications prognosis.
This description comes directly from the study's public registry record.
Artem Gubko, Ph.D. · +79684241490 · gubko@artvig.ru
Boris Akselrod, Professor · +79257403797 · aksel@mail.ru
Always discuss trial participation with your own doctor first.
| Petrovsky Research National Centre of Surgery (Petrovsky NRCS) | Moscow, Moscow, Russia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06336213